![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2024
Simpson, Eric L.; Blauvelt, Andrew; Silverberg, Jonathan I.; Cork, Michael J.; Katoh, Norito; Mark, Thomas; Schneider, Shannon K. R. und Wollenberg, Andreas 
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2024):
Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1.
In: American Journal of Clinical Dermatology, Bd. 25, Nr. 1: S. 139-148
[PDF, 1MB]
2023
Simpson, Eric L.; Pink, Andrew E.; Blauvelt, Andrew; Gooderham, Melinda; Armstrong, April W.; Worm, Margitta; Katoh, Norito; Peris, Ketty; Puig, Luis; Barbarot, Sébastien; Mark, Thomas; Steffensen, Louise Abildgaard; Tindberg, Ann-Marie und Wollenberg, Andreas ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]